Quarterly Balance Sheet

Noile-Immune Biotech Inc. - Filing #7270247

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
4,670,939,000 JPY
5,555,691,000 JPY
Other
779,000 JPY
2,157,000 JPY
Current assets
4,775,376,000 JPY
5,717,089,000 JPY
Non-current assets
Investments and other assets
24,796,000 JPY
61,857,000 JPY
Investments and other assets
Long-term prepaid expenses
1,230,000 JPY
2,699,000 JPY
Non-current assets
24,796,000 JPY
61,857,000 JPY
Assets
4,800,172,000 JPY
5,778,946,000 JPY
Liabilities
Current liabilities
Income taxes payable
23,616,000 JPY
30,210,000 JPY
Current liabilities
69,441,000 JPY
86,260,000 JPY
Non-current liabilities
Asset retirement obligations
5,233,000 JPY
5,233,000 JPY
Non-current liabilities
5,233,000 JPY
5,233,000 JPY
Liabilities
74,675,000 JPY
91,494,000 JPY
Net assets
Shareholders' equity
Share capital
4,047,254,000 JPY
4,045,977,000 JPY
Capital surplus
4,025,098,000 JPY
4,023,821,000 JPY
Retained earnings
-3,353,702,000 JPY
-2,389,247,000 JPY
Shareholders' equity
4,718,649,000 JPY
5,680,550,000 JPY
Share acquisition rights
6,847,000 JPY
6,901,000 JPY
Net assets
6,847,000 JPY
-3,353,702,000 JPY
4,725,497,000 JPY
4,047,254,000 JPY
4,025,098,000 JPY
4,718,649,000 JPY
4,045,977,000 JPY
-2,389,247,000 JPY
6,901,000 JPY
5,680,550,000 JPY
5,687,452,000 JPY
4,023,821,000 JPY
4,293,716,000 JPY
4,300,617,000 JPY
2,787,552,000 JPY
-1,259,232,000 JPY
6,901,000 JPY
2,765,396,000 JPY
Liabilities and net assets
4,800,172,000 JPY
5,778,946,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.